Evaluate the following patient presentations, all of whom are found to have a non-anion gap metabolic acidosis. Match each patient's clinical and laboratory profile with the primary underlying pathophysiologic mechanism responsible for their condition.
- A 35-year-old woman with recurrent calcium phosphate nephrolithiasis, a serum of mEq/L, and a urine pH of .Impaired -intercalated cell hydrogen ion secretion in the distal tubule
- A 42-year-old man with multiple myeloma, a serum of mEq/L, a urine pH of , and isolated glycosuria.Decreased proximal tubule bicarbonate reabsorption
- A 68-year-old man with advanced diabetic nephropathy, a serum of mEq/L, and a urine pH of .Hyporeninemic hypoaldosteronism causing reduced principal cell cation exchange
- A 24-year-old woman with chronic generalized weakness, a serum of mEq/L, a urine pH of , and a negative urine anion gap.Severe lower gastrointestinal bicarbonate loss leading to appropriate renal ammonium excretion
Answer
The correct pairings align the patient with nephrolithiasis and high urine pH to Type 1 RTA; the patient with myeloma and glycosuria to Type 2 RTA; the diabetic patient with hyperkalemia to Type 4 RTA; and the patient with a negative urine anion gap to gastrointestinal bicarbonate loss.
Each clinical vignette provides specific physiologic markers that pinpoint the source of the non-anion gap metabolic acidosis. Hyperkalemia isolates Type 4 RTA. Among the hypokalemic etiologies, an alkaline urine pH isolates Type 1 RTA. For the remaining hypokalemic and aciduric patients, a negative urine anion gap identifies extrarenal (GI) loss, while signs of Fanconi syndrome isolate Type 2 RTA.
Step-by-Step Solution
Key Concept
Differentiation of non-anion gap metabolic acidosis requires sequential evaluation of serum potassium, urine pH, and the urine anion gap to distinguish between gastrointestinal losses and the three main types of renal tubular acidosis.